Financhill
Sell
38

MSTR Quote, Financials, Valuation and Earnings

Last price:
$158.71
Seasonality move :
19.12%
Day range:
$155.10 - $159.28
52-week range:
$155.61 - $457.22
Dividend yield:
0%
P/E ratio:
7.34x
P/S ratio:
91.44x
P/B ratio:
0.87x
Volume:
15.9M
Avg. volume:
21.3M
1-year change:
-55.69%
Market cap:
$45.4B
Revenue:
$463.5M
EPS (TTM):
$21.50

Earnings Data

Next earnings date for MSTR
Feb 05
2026
Most recent earnings per share
$8.42
Missed by $22.85
(Oct 30/2025)
Consensus Estimate
$31.27
(Oct 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MSTR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/05/2026 Q4 $117.4M -- -- $38.29 --
10/30/2025 Q3 $116.9M $128.7M $8.42 $31.27 -$22.85
07/31/2025 Q2 $112.5M $114.5M $32.60 $21.48 $11.12
05/01/2025 Q1 $116.4M $111.1M -$16.49 -$0.02 -$16.46
02/05/2025 Q4 $122.7M $120.7M -$3.03 $0.06 -$3.09
10/30/2024 Q3 $121.5M $116.1M -$1.72 -$0.02 -$1.71
08/01/2024 Q2 $122M $111.4M -$0.57 -$0.02 -$0.55
04/29/2024 Q1 $121.4M $115.2M -$0.31 -$0.01 -$0.30
02/06/2024 Q4 $132.2M $124.5M $0.50 $0.02 $0.48
11/01/2023 Q3 -- $129.5M -$10.09 -- --
08/01/2023 Q2 -- $120.4M $1.52 -- --
05/01/2023 Q1 -- $121.9M $31.79 -- --
02/02/2023 Q4 -- $132.6M -$2.19 -- --
11/01/2022 Q3 -- $125.4M -$2.39 -- --
08/02/2022 Q2 -- $122.1M -$94.01 -- --
05/03/2022 Q1 -- $119.3M -$11.58 -- --
02/01/2022 Q4 -- $134.5M -$0.84 -- --
10/28/2021 Q3 -- $128M -$3.61 -- --
07/29/2021 Q2 -- $125.4M -$30.71 -- --
04/29/2021 Q1 -- $122.9M -$11.40 -- --
01/28/2021 Q4 -- $131.3M $0.03 -- --
10/27/2020 Q3 -- $127.4M -$1.48 -- --
07/28/2020 Q2 -- $110.6M $0.35 -- --
03/31/2020 Q1 -- $111.4M $0.07 -- --
12/31/2019 Q4 -- $133.5M $0.12 -- --
10/29/2019 Q3 -- $119.7M $0.09 -- --
07/30/2019 Q2 -- $117.7M $0.20 -- --
04/30/2019 Q1 -- $115.4M -$0.08 -- --
01/29/2019 Q4 -- $131.9M $0.03 -- --
10/25/2018 Q3 -- $122.2M $0.11 -- --
07/26/2018 Q2 -- $120.6M $0.04 -- --
04/26/2018 Q1 -- $123M $0.02 -- --
01/25/2018 Q4 -- $136.4M -$0.22 -- --
10/26/2017 Q3 -- $126M $0.16 -- --
07/27/2017 Q2 -- $119.2M $0.09 -- --
04/27/2017 Q1 -- $122.2M $0.13 -- --
01/31/2017 Q4 -- $140.1M $0.27 -- --
10/27/2016 Q3 -- $129.9M $0.23 -- --
07/28/2016 Q2 -- $123.1M $0.16 -- --
04/27/2016 Q1 -- $119M $0.12 -- --
01/27/2016 Q4 -- $143.5M $0.34 -- --

Strategy, Inc. Earnings Questions

  • How Much did Strategy, Inc. Generate in Revenue Last Quarter?

    Strategy, Inc. reported $128.7M worth of top line sales in its most recent quarter.

  • Did Strategy, Inc. Beat Earnings Last Quarter?

    Strategy, Inc. announced earnings per share of $8.42 which represents a miss of analyst forecast a $31.27 per share.

  • Is Strategy, Inc. Profitable?

    Strategy, Inc. reported $90.7M that represents $0.29 per share over the last quarter.

  • What is the Analyst Consensus for Strategy, Inc. EPS Next Year?

    Strategy, Inc.'s earnings are forecast to decrease from -$6.06 per share to -$3.08 per share next year representing a decrease of -98.01%.

  • When is Strategy, Inc.'s Earnings Date?

    Strategy, Inc.'s next earnings date is February 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock